HCPCS Level IIdrugActive
J2185
Meropenem
BETOS: O1E
Effective: 2004-01-01
Referenced in 1 policies
Description
Injection, meropenem, 100 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Meropenem
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
100 MG
Billing Units
5.0000
29
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.